Table 1.
Putative marker | Tumor sphere formation (in vitro) | Tumor formation during serial engraftment (in vivo) | Limiting dilution assay | Chemo-resistance | Others | Ref. |
CD44 | + | + | Not conducted | + | (1) Capacity of cell differentiation (2) Giving rise to both CD44+ and CD44- GC cells (3) Independent prognostic factor of GC patients | Takaishi et al[29] Yoon et al[119] |
CD44/CD24 | + | + | + | Not conducted | Capacity of cell differentiation | Zhang et al[32] |
CD44/CD54 | + | + | + | Not conducted | (1) Capacity of cell differentiation (2) Detectable from peripheral blood | Chen et al[33] |
CD44/CD26 | + | + | Not conducted | + | / | Nishikawa et al[127] |
CD44/EpCam | + | + | + | + | (1) Capacity of cell differentiation (2) Restoration of histological heterogeneity from single CD44/EpCam+ cell | Han et al[31] |
CD44v810/EpCAM | + | + | + | + | CD44v8-10 but not CD44 standard increase the frequency of tumor initiation | Lau et al[30] |
CD90 | + | + | + | + | Restoration of cellular hierarchy from single CD90+ cell | Jiang et al[35] |
CD133 | + | + | Not conducted | + | Independent prognostic factor of GC patients | Zhang et al[128] |
Lgr5 | + | + | Not conducted | Not conducted | / | Wang et al[40] |
ALDH | + | + | + | + | / | Nishikawa et al[42] |
ALDH1/REG4 | Katsuno et al[45] | |||||
Oct4/Sox2/Nanog | + | + | Not conducted | + | Independent prognostic factor of GC patients | Liu et al[129] |
ALDH: Aldehyde dehydrogenase; GC: Gastric cancer.